Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
PNU 74654: Wnt Signaling Pathway Inhibitor
2026-09-04
PNU 74654 is a small-molecule Wnt signaling pathway inhibitor supplied for research on Wnt/β-catenin signaling inhibition, cancer biology, and stem cell regulation. Its documented formulation profile supports DMSO-based workflows, while peer-reviewed evidence establishes pathway relevance but does not by itself validate PNU 74654 in every biological model.
-
Annexin V-FITC/PI Apoptosis Assay Kit Workflow
2026-09-04
Resolve viable, early apoptotic, late apoptotic, and membrane-compromised cells in a rapid two-parameter workflow. This practical guide applies the assay to hypoxia-activated cancer therapies, including the BNNC photomolecular glue strategy, while emphasizing controls, gating, and troubleshooting.
-
QNZ (EVP4593): NF-κB Research Workflows
2026-09-03
QNZ (EVP4593) gives researchers a nanomolar tool for connecting NF-κB reporter output with TNF-α and calcium phenotypes, from Jurkat inflammation assays to YAC128 Huntington’s disease models. This workflow emphasizes solvent control, orthogonal readouts, and careful separation of infection surveillance from mechanistic claims.
-
Naftifine HCl: A Rigorous Assay Design Guide
2026-09-03
Naftifine HCl is an allylamine antifungal agent whose sterol-directed mechanism supports precise fungal biology assays. This article connects assay design principles from a landmark WNT5a/GSK3/β-catenin study to reproducible antifungal research without conflating distinct biological systems.
-
BIRB 796: Precision p38α MAPK Workflows
2026-09-02
BIRB 796 (Doramapimod) combines strong p38α selectivity with an allosteric mechanism suited to inflammation research, cytokine production inhibition, and apoptosis assays. This practical guide covers dosing design, phospho-signaling workflows, dephosphorylation-focused experiments, and troubleshooting for reproducible cell and animal studies.
-
EGCG: From Green Tea Catechin to Precision Bioassay
2026-09-02
(-)-Epigallocatechin gallate (EGCG) is more than a green tea antioxidant: its biological effects depend on dose, delivery mode, cell context, and assay design. This guide uses 3D-printed calcium phosphate scaffold research to define a practical framework for apoptosis, angiogenesis, osteogenesis, and cancer chemoprevention studies.
-
POx-Lipid LNPs for mRNA Delivery: Study Insights
2026-09-01
This 2025 Small study evaluates poly(2-ethyl-2-oxazoline)-based lipids as alternatives to PEG-lipids in mRNA lipid nanoparticles. By combining polymer-length control, physicochemical characterization, transfection testing, immunoreaction analysis, and super-resolution microscopy, the authors identify a PEtOx-LNP formulation that outperforms the tested commercial PEG-lipid benchmark under the study conditions.
-
Gamithromycin: From Lung PK to Better Assays
2026-09-01
Gamithromycin research is strongest when pulmonary exposure, extracellular susceptibility, and intracellular activity are measured together. This assay-focused guide translates pharmacokinetic evidence into practical decisions for veterinary respiratory infection studies.
-
Cy5-UTP for Mechanistic RNA Probe Design
2026-08-31
Cy5-UTP enables direct fluorescent RNA probe synthesis while preserving a pathway to structure-aware RNA–protein assays. This article explains how Cyanine 5-uridine triphosphate can support XIST–SPEN research, FISH, and multiplexed RNA analysis without confusing fluorescence with molecular function.
-
Omeprazole (A2845): Gastric Acid Research Guide
2026-08-31
Omeprazole (A2845) provides a defined H+,K+-ATPase inhibitor starting point for gastric acid secretion research, including controlled acid-stimulation assays and antiulcer activity studies. It is intended only for scientific research; its dossier values should not be interpreted as clinical efficacy or as evidence for treating gastric acid-related disorders.
-
HyperScribe™ Poly (A) Tailing Kit: RNA Workflow
2026-08-30
Convert in vitro-transcribed RNA into a research-ready substrate for transfection, micro-injection, and functional rescue assays. The HyperScribe™ Poly (A) Tailing Kit combines E. coli Poly (A) Polymerase with ATP-dependent tailing to support mRNA stability enhancement and more consistent translation-focused experiments.
-
Idoxuridine: A Mechanism-First Assay Framework
2026-08-29
Idoxuridine and 5-iodo-2'-deoxyuridine enable precise investigation of viral DNA synthesis inhibition. This article presents a mechanism-first assay framework that combines orthogonal virology readouts with lessons from a human-neuron translational study.
-
V5 Epitope Tag Peptide: Workflow & Use Cases
2026-08-28
Use the V5 Epitope Tag Peptide as a sequence-specific control for recombinant protein detection, immunoprecipitation, and localization experiments. Its high purity and strong solubility also support antibody-specificity testing and a practical bridge from endpoint assays to dynamic single-molecule imaging.
-
JZL184 and the CB1–CREB–GLT-1 Translational Axis
2026-08-28
JZL184 offers a mechanistically precise way to interrogate monoacylglycerol lipase control of 2-AG, CB1 signaling, and astrocytic GLT-1 regulation. This thought-leadership perspective connects the compound to traumatic brain injury research while defining practical safeguards for translational interpretation.
-
Latrunculin A as a Causal Probe of Viral Cytoskeletons
2026-08-27
Latrunculin A is a reversible inhibitor of actin assembly that converts cytoskeletal perturbation into a testable strategy for viral cell biology. This article explains how to interpret actin–myosin network findings, choose orthogonal assays, and avoid confusing host-factor dependence with direct antiviral activity.